Published in Medical Letter on the CDC and FDA, June 24th, 2007
“We had great hope that folic acid would be a very cheap and effective agent to prevent large bowel adenomas. We expected that folic acid would decrease the risk for colorectal cancers, perhaps as much as 40 percent. So these results are disappointing,” said Robert Sandler, M.D., a study co-author and chief of the division of gastroenterology and hepatology in the University of North Carolina at Chapel Hill School of Medicine.
In addition, the government-mandated addition of folic acid to common...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.